- Home
- FLGT vs TXO Comparison
FLGT vs TXO Comparison
Compare FLGT & TXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- TXO
- Stock Information
- Founded
- FLGT 2011
- TXO 2012
- Country
- FLGT United States
- TXO United States
- Employees
- FLGT N/A
- TXO N/A
- Industry
- FLGT Medical Specialities
- TXO Oil & Gas Production
- Sector
- FLGT Health Care
- TXO Energy
- Exchange
- FLGT Nasdaq
- TXO Nasdaq
- Market Cap
- FLGT 697.3M
- TXO 701.2M
- IPO Year
- FLGT 2016
- TXO 2023
- Fundamental
- Price
- FLGT $30.25
- TXO $12.30
- Analyst Decision
- FLGT Buy
- TXO Strong Buy
- Analyst Count
- FLGT 3
- TXO 2
- Target Price
- FLGT $28.33
- TXO $20.50
- AVG Volume (30 Days)
- FLGT 411.7K
- TXO 242.7K
- Earning Date
- FLGT 11-07-2025
- TXO 11-04-2025
- Dividend Yield
- FLGT N/A
- TXO 19.74%
- EPS Growth
- FLGT N/A
- TXO N/A
- EPS
- FLGT N/A
- TXO 0.36
- Revenue
- FLGT $315,549,000.00
- TXO $364,412,000.00
- Revenue This Year
- FLGT $15.19
- TXO $32.13
- Revenue Next Year
- FLGT $10.58
- TXO $11.48
- P/E Ratio
- FLGT N/A
- TXO $33.94
- Revenue Growth
- FLGT 13.61
- TXO 27.66
- 52 Week Low
- FLGT $14.57
- TXO $11.85
- 52 Week High
- FLGT $31.04
- TXO $20.70
- Technical
- Relative Strength Index (RSI)
- FLGT 71.79
- TXO 31.50
- Support Level
- FLGT $28.65
- TXO $11.85
- Resistance Level
- FLGT $31.04
- TXO $14.09
- Average True Range (ATR)
- FLGT 1.33
- TXO 0.40
- MACD
- FLGT 0.21
- TXO -0.13
- Stochastic Oscillator
- FLGT 87.98
- TXO 18.75
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.